New hope for kids with drug-resistant HIV: experimental combo shows promise
NCT ID NCT04648280
First seen Nov 01, 2025 · Last updated Apr 28, 2026 · Updated 25 times
Summary
This study tests a new HIV drug called fostemsavir in children and teens (ages 6 to 17) whose current HIV medicines are no longer working because the virus has become resistant. The drug is given along with other tailored HIV medicines. The goal is to see if it is safe and can lower the amount of virus in the blood. About 60 participants will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS WITH MULTI DRUG RESISTANT VIRUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's Healthcare of Atlanta
Atlanta, Georgia, 30322, United States
-
FAM-CRU
Cape Town, South Africa
-
Hospital Federal dos Servidores do Estado
Rio de Janeiro, 20221-161, Brazil
-
Hospital Geral de Nova Iguaçu
Nova Iguaçu, Brazil
-
King Edward VIII Hospital
Durban, South Africa
-
PHRU
Soweto, South Africa
-
Rahima Moosa Mother and Child Hospital
Johannesburg, 2112, South Africa
-
Wits Reproductive Health and HIV Institutel
Johannesburg, South Africa
Conditions
Explore the condition pages connected to this study.